{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T23:25:19Z","timestamp":1793057119188,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1007\/s00192-020-04490-3","type":"journal-article","created":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T11:02:56Z","timestamp":1599217376000},"page":"1061-1071","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Comparative effectiveness and safety of intravesical instillation treatment of interstitial cystitis\/bladder pain syndrome: a systematic review and network meta-analysis of randomized controlled trials"],"prefix":"10.1007","volume":"32","author":[{"given":"Shengzhuo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liao","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-036X","authenticated-orcid":false,"given":"Deyi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,4]]},"reference":[{"issue":"1","key":"4490_CR1","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1067\/mob.2002.125704","volume":"187","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol. 2002;187(1):116\u201326.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"4490_CR2","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/j.juro.2011.03.064","volume":"185","author":"PM Hanno","year":"2011","unstructured":"Hanno PM, Burks DA, Clemens JQ, Dmochowski RR, Erickson D, Fitzgerald MP, et al. AUA guideline for the diagnosis and treatment of interstitial cystitis\/bladder pain syndrome. J Urol. 2011;185(6):2162\u201370. https:\/\/doi.org\/10.1016\/j.juro.2011.03.064.","journal-title":"J Urol"},{"issue":"1","key":"4490_CR3","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/nau.20513","volume":"28","author":"Y Song","year":"2009","unstructured":"Song Y, Zhang W, Xu B, Hao L, Song J. Prevalence and correlates of painful bladder syndrome symptoms in Fuzhou Chinese women. Neurourol Urodyn. 2009;28(1):22\u20135. https:\/\/doi.org\/10.1002\/nau.20513.","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"4490_CR4","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.eururo.2006.08.028","volume":"51","author":"C Temml","year":"2007","unstructured":"Temml C, Wehrberger C, Riedl C, Ponholzer A, Marszalek M, Madersbacher S. Prevalence and correlates for interstitial cystitis symptoms in women participating in a health screening project. Eur Urol 2007;51(3):803\u2013809.","journal-title":"Eur Urol"},{"issue":"3","key":"4490_CR5","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/j.1464-410X.2010.09843.x","volume":"107","author":"CL Parsons","year":"2011","unstructured":"Parsons CL. The role of a leaky epithelium and potassium in the generation of bladder symptoms in interstitial cystitis\/overactive bladder, urethral syndrome, prostatitis and gynaecological chronic pelvic pain. BJU Int. 2011;107(3):370\u20135. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09843.x.","journal-title":"BJU Int"},{"issue":"139","key":"4490_CR6","first-page":"243","volume":"25","author":"K Duh","year":"2018","unstructured":"Duh K, Funaro MG, DeGouveia W, Bahlani S, Pappas D, Najjar S, et al. Crosstalk between the immune system and neural pathways in interstitial cystitis\/bladder pain syndrome. Discov Med. 2018;25(139):243\u201350.","journal-title":"Discov Med"},{"issue":"2","key":"4490_CR7","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.1464-410X.1997.03384.x","volume":"79","author":"JJ Bade","year":"1997","unstructured":"Bade JJ, Laseur M, Nieuwenburg A, van der Weele LT, Mensink HJ. A placebo-controlled study of intravesical pentosanpolysulphate for the treatment of interstitial cystitis. Br J Urol. 1997;79(2):168\u201371.","journal-title":"Br J Urol"},{"issue":"1","key":"4490_CR8","first-page":"4989","volume":"17","author":"BL Jacobs","year":"2010","unstructured":"Jacobs BL, Smaldone MC, Tyagi V, Philips BJ, Jackman SV, Leng WW, et al. Increased nerve growth factor in neurogenic overactive bladder and interstitial cystitis patients. Can J Urol. 2010;17(1):4989\u201394.","journal-title":"Can J Urol"},{"issue":"7","key":"4490_CR9","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s00192-017-3547-5","volume":"29","author":"A Furuta","year":"2018","unstructured":"Furuta A, Yamamoto T, Suzuki Y, Gotoh M, Egawa S, Yoshimura N. Comparison of inflammatory urine markers in patients with interstitial cystitis and overactive bladder. Int Urogynecol J. 2018;29(7):961\u20136. https:\/\/doi.org\/10.1007\/s00192-017-3547-5.","journal-title":"Int Urogynecol J"},{"issue":"2","key":"4490_CR10","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.juro.2007.09.022","volume":"179","author":"PJ Hauser","year":"2008","unstructured":"Hauser PJ, Dozmorov MG, Bane BL, Slobodov G, Culkin DJ, Hurst RE. Abnormal expression of differentiation related proteins and proteoglycan core proteins in the urothelium of patients with interstitial cystitis. J Urol. 2008;179(2):764\u20139.","journal-title":"J Urol"},{"issue":"6","key":"4490_CR11","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1111\/j.1464-410X.2009.08467.x","volume":"104","author":"H Kiuchi","year":"2009","unstructured":"Kiuchi H, Tsujimura A, Takao T, Yamamoto K, Nakayama J, Miyagawa Y, et al. Increased vascular endothelial growth factor expression in patients with bladder pain syndrome\/interstitial cystitis: its association with pain severity and glomerulations. BJU Int 2009;104(6):826\u201331; discussion 831. https:\/\/doi.org\/10.1111\/j.1464-410X.2009.08467.x.","journal-title":"BJU Int"},{"issue":"3","key":"4490_CR12","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1097\/01.ju.0000135009.55905.cb","volume":"172","author":"M Tamaki","year":"2004","unstructured":"Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T. Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol. 2004;172(3):945\u20138.","journal-title":"J Urol"},{"issue":"10","key":"4490_CR13","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/14656566.2018.1491968","volume":"19","author":"LL Giusto","year":"2018","unstructured":"Giusto LL, Zahner PM, Shoskes DA. An evaluation of the pharmacotherapy for interstitial cystitis. Expert Opin Pharmacother. 2018;19(10):1097\u2013108. https:\/\/doi.org\/10.1080\/14656566.2018.1491968.","journal-title":"Expert Opin Pharmacother"},{"issue":"6 Pt 1","key":"4490_CR14","first-page":"1900","volume":"165","author":"R Henry","year":"2001","unstructured":"Henry R, Patterson L, Avery N, Tanzola R, Tod D, Hunter D, et al. Absorption of alkalized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J Urol. 2001;165(6 Pt 1):1900\u20133.","journal-title":"J Urol"},{"issue":"1","key":"4490_CR15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.urology.2004.08.056","volume":"65","author":"CL Parsons","year":"2005","unstructured":"Parsons CL. Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology. 2005;65(1):45\u20138.","journal-title":"Urology"},{"issue":"6","key":"4490_CR16","doi-asserted-by":"publisher","first-page":"2090","DOI":"10.1016\/S0022-5347(01)64682-2","volume":"157","author":"K Peters","year":"1997","unstructured":"Peters K, Diokno A, Steinert B, Yuhico M, Mitchell B, Krohta S, et al. The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol. 1997;157(6):2090\u20134.","journal-title":"J Urol"},{"issue":"10","key":"4490_CR17","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/S0024-3205(96)00567-X","volume":"60","author":"G Appendino","year":"1997","unstructured":"Appendino G, Szallasi A. Euphorbium: modern research on its active principle, resiniferatoxin, revives an ancient medicine. Life Sci. 1997;60(10):681\u201396.","journal-title":"Life Sci"},{"issue":"2","key":"4490_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/0306-4522(89)90269-8","volume":"30","author":"A Szallasi","year":"1989","unstructured":"Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience. 1989;30(2):515\u201320.","journal-title":"Neuroscience"},{"issue":"4","key":"4490_CR19","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/s00210-006-0073-2","volume":"373","author":"A Avelino","year":"2006","unstructured":"Avelino A, Cruz F. TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications. Naunyn Schmiedebergs Arch Pharmacol. 2006;373(4):287\u201399.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"4","key":"4490_CR20","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.eururo.2003.12.004","volume":"45","author":"A Reitz","year":"2004","unstructured":"Reitz A, St\u00f6hrer M, Kramer G, Del Popolo G, Chartier-Kastler E, Pannek J, et al. European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity. Eur Urol. 2004;45(4):510\u20135.","journal-title":"Eur Urol"},{"issue":"1","key":"4490_CR21","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1526-4610.2004.04007.x","volume":"44","author":"PL Durham","year":"2004","unstructured":"Durham PL, Cady R, Cady R (2004) Regulation of calcitonin gene-related peptide secretion from trigeminal nerve cells by botulinum toxin type A: implications for migraine therapy. Headache 44 (1):35\u201342; discussion 42\u20133.","journal-title":"Headache"},{"issue":"5","key":"4490_CR22","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/j.juro.2015.01.086","volume":"193","author":"PM Hanno","year":"2015","unstructured":"Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis\/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545\u201353. https:\/\/doi.org\/10.1016\/j.juro.2015.01.086.","journal-title":"J Urol"},{"issue":"8","key":"4490_CR23","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1007\/s00192-015-2890-7","volume":"27","author":"JM Barua","year":"2016","unstructured":"Barua JM, Arance I, Angulo JC, Riedl CR. A systematic review and meta-analysis on the efficacy of intravesical therapy for bladder pain syndrome\/interstitial cystitis. Int Urogynecol J. 2016;27(8):1137\u201347. https:\/\/doi.org\/10.1007\/s00192-015-2890-7.","journal-title":"Int Urogynecol J"},{"issue":"4","key":"4490_CR24","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s00192-016-3079-4","volume":"28","author":"W Zhang","year":"2017","unstructured":"Zhang W, Deng X, Liu C, Wang X. Intravesical treatment for interstitial cystitis\/painful bladder syndrome: a network meta-analysis. Int Urogynecol J. 2017;28(4):515\u201325. https:\/\/doi.org\/10.1007\/s00192-016-3079-4.","journal-title":"Int Urogynecol J"},{"issue":"7","key":"4490_CR25","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097. https:\/\/doi.org\/10.1371\/journal.pmed.1000097.","journal-title":"PLoS Med"},{"key":"4490_CR26","doi-asserted-by":"publisher","first-page":"j4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:j4008. https:\/\/doi.org\/10.1136\/bmj.j4008.","journal-title":"BMJ"},{"key":"4490_CR27","unstructured":"Bob P, Chris B, Dave S, Doug B, Sharon S, Brian H, Martin D. Oxford Centre for evidence-based medicine: levels of evidence. 2009. https:\/\/www.cebm.net\/2009\/06\/oxford-centre-evidence-based-medicine-levels-evidence-march-2009\/"},{"issue":"3","key":"4490_CR28","doi-asserted-by":"publisher","first-page":"270","DOI":"10.5173\/ceju.2019.0007","volume":"72","author":"M \u00d6zk\u0131d\u0131k","year":"2019","unstructured":"\u00d6zk\u0131d\u0131k M. Assessment of long-term intravesical hyaluronic acid, chondroitin sulfate and combination therapy for patients with bladder pain syndrome. Cent European J Urol. 2019;72(3):270\u20135. https:\/\/doi.org\/10.5173\/ceju.2019.0007.","journal-title":"Cent European J Urol"},{"issue":"1","key":"4490_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/nau.23284","volume":"37","author":"\u00d6 G\u00fclp\u0131nar","year":"2018","unstructured":"G\u00fclp\u0131nar \u00d6, Esen B, Kay\u0131\u015f A, G\u00f6k\u00e7e M\u0130, S\u00fcer E. Clinical comparison of intravesical hyaluronic acid and chondroitin sulfate therapies in the treatment of bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2018;37(1):257\u201362. https:\/\/doi.org\/10.1002\/nau.23284.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"4490_CR30","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.juro.2017.02.021","volume":"198","author":"Y-C Chuang","year":"2017","unstructured":"Chuang Y-C, Kuo H-C. A prospective, multicenter, double-blind, randomized trial of bladder instillation of liposome formulation onabotulinumtoxinA for interstitial cystitis\/bladder pain syndrome. J Urol. 2017;198(2):376\u201382. https:\/\/doi.org\/10.1016\/j.juro.2017.02.021.","journal-title":"J Urol"},{"issue":"4","key":"4490_CR31","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1002\/nau.23091","volume":"36","author":"M Cervigni","year":"2017","unstructured":"Cervigni M, Sommariva M, Tenaglia R, Porru D, Ostardo E, Giamm\u00f2 A, et al. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome\/interstitial cystitis. Neurourol Urodyn. 2017;36(4):1178\u201386. https:\/\/doi.org\/10.1002\/nau.23091.","journal-title":"Neurourol Urodyn"},{"issue":"6","key":"4490_CR32","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.urology.2012.01.059","volume":"79","author":"JC Nickel","year":"2012","unstructured":"Nickel JC, Hanno P, Kumar K, Thomas H. Second multicenter, randomized, double-blind, parallel-group evaluation of effectiveness and safety of intravesical sodium chondroitin sulfate compared with inactive vehicle control in subjects with interstitial cystitis\/bladder pain syndrome. Urology. 2012;79(6):1220\u20134. https:\/\/doi.org\/10.1016\/j.urology.2012.01.059.","journal-title":"Urology"},{"issue":"4","key":"4490_CR33","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.urology.2010.03.016","volume":"76","author":"JC Nickel","year":"2010","unstructured":"Nickel JC, Egerdie RB, Steinhoff G, Palmer B, Hanno P. A multicenter, randomized, double-blind, parallel group pilot evaluation of the efficacy and safety of intravesical sodium chondroitin sulfate versus vehicle control in patients with interstitial cystitis\/painful bladder syndrome. Urology. 2010;76(4):804\u20139. https:\/\/doi.org\/10.1016\/j.urology.2010.03.016.","journal-title":"Urology"},{"issue":"7","key":"4490_CR34","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/j.1464-410X.2008.08162.x","volume":"103","author":"JC Nickel","year":"2009","unstructured":"Nickel JC, Moldwin R, Lee S, Davis EL, Henry RA, Wyllie MG. Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome. BJU Int. 2009;103(7):910\u20138. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.08162.x.","journal-title":"BJU Int"},{"issue":"2","key":"4490_CR35","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1016\/j.juro.2007.09.035","volume":"179","author":"KJ Propert","year":"2008","unstructured":"Propert KJ, Mayer R, Nickel JC, Payne CK, Peters KM, Teal V, et al. Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol. 2008;179(2):552\u20135.","journal-title":"J Urol"},{"issue":"4","key":"4490_CR36","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1097\/01.ju.0000152337.82806.e8","volume":"173","author":"R Mayer","year":"2005","unstructured":"Mayer R, Propert KJ, Peters KM, Payne CK, Zhang Y, Burks D, et al. A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis. J Urol. 2005;173(4):1186\u201391.","journal-title":"J Urol"},{"issue":"4","key":"4490_CR37","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s00192-005-1307-4","volume":"16","author":"TYH Chen","year":"2005","unstructured":"Chen TYH, Corcos J, Camel M, Ponsot Y, Tu LM. Prospective, randomized, double-blind study of safety and tolerability of intravesical resiniferatoxin (RTX) in interstitial cystitis (IC). Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(4):293\u20137.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"issue":"2","key":"4490_CR38","first-page":"90","volume":"1","author":"D Irani","year":"2004","unstructured":"Irani D, Heidari M, Khezri AA. The efficacy and safety of intravesical Bacillus-Calmette-Guerin in the treatment of female patients with interstitial cystitis: a double-blinded prospective placebo controlled study. Urol J. 2004;1(2):90\u20133.","journal-title":"Urol J"},{"issue":"5","key":"4490_CR39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00192-013-2267-8","volume":"25","author":"J Manning","year":"2014","unstructured":"Manning J, Dwyer P, Rosamilia A, Colyvas K, Murray C, Fitzgerald E. A multicentre, prospective, randomised, double-blind study to measure the treatment effectiveness of abobotulinum a (AboBTXA) among women with refractory interstitial cystitis\/bladder pain syndrome. Int Urogynecol J. 2014;25(5):593\u20139. https:\/\/doi.org\/10.1007\/s00192-013-2267-8.","journal-title":"Int Urogynecol J"},{"issue":"5","key":"4490_CR40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/nau.22760","volume":"35","author":"H-C Kuo","year":"2016","unstructured":"Kuo H-C, Jiang Y-H, Tsai Y-C, Kuo Y-C. Intravesical botulinum toxin-A injections reduce bladder pain of interstitial cystitis\/bladder pain syndrome refractory to conventional treatment\u2014a prospective, multicenter, randomized, double-blind, placebo-controlled clinical trial. Neurourol Urodyn. 2016;35(5):609\u201314. https:\/\/doi.org\/10.1002\/nau.22760.","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"4490_CR41","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1002\/nau.20946","volume":"30","author":"HP Gottsch","year":"2011","unstructured":"Gottsch HP, Miller JL, Yang CC, Berger RE. A pilot study of botulinum toxin for interstitial cystitis\/painful bladder syndrome. Neurourol Urodyn. 2011;30(1):93\u20136. https:\/\/doi.org\/10.1002\/nau.20946.","journal-title":"Neurourol Urodyn"},{"key":"4490_CR42","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/j.juro.2007.08.170","volume":"2","author":"M Rasheed","year":"2007","unstructured":"Rasheed M, Farahat Y, Bahnasy A, Damhougy M (2007) A randomized controlled trial of bacillus Calmette-Guerin and botulinum toxin-A for the treatment of refractory interstitial cystitis. Neurourol Urodyn. 2:735. https:\/\/doi.org\/10.1016\/j.juro.2007.08.170","journal-title":"Neurourol Urodyn"},{"issue":"1","key":"4490_CR43","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.juro.2007.08.170","volume":"179","author":"EL Davis","year":"2008","unstructured":"Davis EL, El Khoudary SR, Talbott EO, Davis J, Regan LJ. Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol. 2008;179(1):177\u201385. https:\/\/doi.org\/10.1016\/j.juro.2007.08.170.","journal-title":"J Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04490-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-020-04490-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-020-04490-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,4]],"date-time":"2021-09-04T01:29:17Z","timestamp":1630718957000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-020-04490-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,4]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4490"],"URL":"https:\/\/doi.org\/10.1007\/s00192-020-04490-3","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,4]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All relevant permissions have been obtained.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Written permission"}}]}}